Our products

We manufacture high-quality generic medicines that enable us to expand the access of patients and healthcare professionals to valuable treatments.

Among the more than 400 pharmaceutical companies in Romania, not many have the ability to develop a pharmaceutical product from idea to finished medicine. By embracing the portfolio development concept “from molecule to market”, we have differentiated ourselves from other medicine manufacturers, today owning a complex portfolio of over 160 medicines in 8 pharmaceutical forms (sterile powders for injection, capsules, tablets, ointments, gels, creams, pessaries and suppositories), from 11 therapeutic classes.

At present, Antibiotice products are among the first recommendations made by the health professionals, doctors and pharmacists, for the treatment of systemic infectious and digestive tract diseases, cardiovascular, metabolic, dermatological, central nervous system disorders, as well as for supporting a healthy lifestyle.

We manufacture, as well, with science and soul:

medicines and food supplements for veterinary use;
active substances based on biotechnologies derived from streptomyces noursei for pharmaceutical use (compacted, micronized and standard nystatin – for which we are the world leader);
biofertilizers;
biocides for disinfecting surfaces and hands.

51 medicines from our portfolio are considered essential (medicines that meet the health care needs of the majority of the population, used for treating the most widespread diseases) according to the World Health Organization classification.

Also, the Antibiotice portfolio includes 25 critical medicines (the critical medicines list published by the European Medicines Agency contains more than 200 active substances used in human medicines which are considered essential), such as:

Vancomycin Atb®
Ampicillin Atb®
Amoxicillin Atb®
Amoxiplus®
Ampiplus®
Cefotaxime Atb®
Cefuroxime Atb®
Cipro Quin®

All the products from the portfolio are carefully monitored, our company constantly taking actions to adapt itself to national and international requirements and regulations by analyzing therapeutic trends, medical guidelines and new efficacy and safety studies in the pharmaceutical field.

After almost seven decades of existence, we have become a well-known brand in Romania, which brings health to millions of people in the country and abroad. In the coming years, we will continue to develop the product portfolio in accordance with the new therapeutic trends, always keeping the patient’s health at the core of our activities. We will enrich the portfolios of anti-infective medicines, topicals, developing also new products for chronic conditions (mainly cardiovascular conditions) and for increasing the quality of life and family health.